Machine learning assessment of endoscopic severity in Ulcerative Colitis trials: Model evaluation against the 2+1 reference standard

被引：0

作者：

Battioui, C. ^{[1
]}

Brodskiy, P. ^{[2
]}

Gottlieb, K. ^{[1
]}

Haft-Javaherian, M. ^{[2
]}

Eastman, W. ^{[1
]}

Lehrer, J. ^{[2
]}

Yu, E. ^{[2
]}

Onken, D. ^{[3
]}

Thomason, D. ^{[4
]}

Colucci, D. ^{[4
]}

Reinisch, W. ^{[5
]}

Baxi, S. ^{[4
]}

机构：

[1] Eli Lilly & Co, Clin Res, Indianapolis, IN USA

[2] Iterat Hlth Inc, Machine Learning, Cambridge, MA USA

[3] Eli Lilly & Co, Data Sci, Indianapolis, IN USA

[4] Iterat Hlth Inc, Data & Insights, Cambridge, MA USA

[5] Med Univ Vienna, Gastroenterol & Hepatol, Vienna, Austria

来源：

关键词：

D O I：

10.1093/ecco-jcc/jjae190.0117

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

DOP078

引用

页码：i227 / i228

页数：2

共 4 条

[1] Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials
Feagan, Brian G.
Khanna, Reena
Sandborn, William J.
Vermeire, Severine
Reinisch, Walter
Su, Chinyu
Salese, Leonardo
Fan, Haiyun
Paulissen, Jerome
Woodworth, Deborah A.
Niezychowski, Wojciech
Sands, Bruce E.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (11-12) : 1442 - 1453
[2] Food and Drug Administration, 2022, Ulcerative Colitis: Developing Drugs for Treatment Internet
[3] Hashash J. G., 2024, Inflammatory Bowel Diseases
[4] Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease
Wils, Pauline
Jairath, Vipul
Sands, Bruce E.
Magro, Fernando
Reinisch, Walter
Rubin, David
Danese, Silvio
Baumann, Cedric
Peyrin-Biroulet, Laurent
[J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (08) : 797 - 806